INVO Fertility, Inc. (IVF)
| Market Cap | 2.55M +116.5% |
| Revenue (ttm) | 6.94M -11.7% |
| Net Income | -29.21M |
| EPS | -1,062.97 |
| Shares Out | 1.62M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 21,192 |
| Open | 1.660 |
| Previous Close | 1.585 |
| Day's Range | 1.550 - 1.690 |
| 52-Week Range | 1.550 - 277.200 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 26, 2026 |
About IVF
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in... [Read more]
Financial Performance
Financial StatementsNews
INVO Fertility receives Nasdaq notice regarding late Form 10-K filing
INVO Fertility (IVF) announced that on April 23, it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the company that it is not…
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
SARASOTA, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reprodu...
INVO Fertility Inc trading halted, news pending
19:50 EDT INVO Fertility (IVF) Inc trading halted, news pending
INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026
SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-5 reve...
INVO Fertility announces availability of advanced incubation technology
INVO Fertility (IVF) announced the adoption of time-lapse incubation technology at its Wisconsin clinic. “This integration reflects INVO’s commitment to providing high-quality, modern laboratory care ...
INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic
SARASOTA, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reprodu...
INVO Fertility’s Wisconsin clinic joins Progyny network
INVO Fertility (IVF) announced that its Wisconsin Fertility Institute clinic has joined the Progyny (PGNY) network. Progyny provides fertility and family-building benefits to an estimated 7.2 million ...
INVO Fertility's Wisconsin Clinic Joins Progyny Network
INVO's Wisconsin Clinic is now in-network for Progyny members, expanding the clinic's market reach INVO's Wisconsin Clinic is now in-network for Progyny members, expanding the clinic's market reach
INVO Fertility closes acquisition of Indiana-based fertility clinic
INVO Fertility (IVF) announced that it has successfully closed the previously announced acquisition of Family Beginnings, P.C., a fertility clinic serving patients across Indiana and the broader Midwe...
INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”
SARASOTA, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation ...
INVO Fertility announces patent issuance for modified INVOcell device
INVO Fertility (IVF) announced the final issuance of a U.S. patent covering a modified version of its proprietary INVOcell device. The patent became effective on February 10, 2026, providing intellect...
INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
New patent extends intellectual property protection on the Company's INVOcell device through 2040 New patent extends intellectual property protection on the Company's INVOcell device through 2040
INVO Fertility upgraded to Buy from Hold at Maxim
Maxim upgraded INVO Fertility (IVF) to Buy from Hold with a $4 price target
INVO Fertility issues letter to shareholders
INVO Fertility (IVF) issued a shareholder letter from its Chief Executive Officer, Steve Shum, outlining the Company’s strengthened fundamental position and its strategic outlook for continued growth....
INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
SARASOTA, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation ...
INVO Fertility files to sell 9.47M shares of common stock for holders
16:50 EST INVO Fertility (IVF) files to sell 9.47M shares of common stock for holders
INVO Fertility Transcript: EGM 2026
Stockholders approved all five proposals, including auditor ratification, share issuance, authorized share increase, and stock plan amendment, supporting the company's strategic growth plan for the year.
Retail Investors Push INVO Fertility (IVF) Stock Higher; Here’s What’s Ahead
Nobody likes a mystery rally, but the wild ride in INVO Fertility (NASDAQ:IVF) over the past few sessions has left traders scratching their heads and checking their charts. As of…
Why Is INVO Fertility Stock (IVF) Up Today?
INVO Fertility stock surged on Tuesday alongside heavy trading of the company’s shares.
INVO Fertility Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit
The discussion highlighted a dual focus on fertility clinic operations and innovative technology, with growth driven by both organic initiatives and acquisitions. Recent policy changes and telehealth expansion are fueling demand, while a renewed emphasis on device promotion and a robust acquisition pipeline position the company for significant progress in 2026.
INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation ...
INVO Fertility names Terah Krigsvold CFO
INVO Fertility (IVF) announced changes to its executive leadership team. Terah Krigsvold, who has served as INVO’s controller since December 2020, has been appointed as the company’s new chief financi...
INVO Fertility files to sell 7.37M shares of common stock for holders
16:44 EST INVO Fertility (IVF) files to sell 7.37M shares of common stock for holders
INVO Fertility signs purchase agreement to acquire Family Beginnings
INVO Fertility (IVF) announced that it has signed a definitive purchase agreement to acquire Family Beginnings, a respected fertility clinic serving patients across Indiana and the broader Midwest. Th...
INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
SARASOTA, Fla. and INDIANAPOLIS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisitio...